MapLight Therapeutics (MPLT) Non-Current Assets (2024 - 2025)
MapLight Therapeutics (MPLT) reported Non-Current Assets of $154.8 million for Q4 2025, up 593.92% on a YoY basis from $22.3 million in Q4 2024, and up 1199.45% sequentially from $11.9 million in Q3 2025.
MapLight Therapeutics (MPLT) Non-Current Assets (2024 - 2025) Analysis & Trends
MapLight Therapeutics (MPLT) has 2 years of Non-Current Assets data on file, last reported at $154.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | MapLight Therapeutics | 305.82 Mn | 305.82 Mn | - | 154.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 154.84 Mn |
| Sep 30, 2025 | 11.92 Mn |
| Dec 31, 2024 | 22.31 Mn |